The Association Between Hysterectomy and Ovarian Cancer Risk: A Population-Based Record-Linkage Study
article
OA: bronze
CC0
⤵ 10 in-corpus citations
AI-generated summary
Hysterectomy without oophorectomy was not associated with overall ovarian cancer risk, but was associated with decreased risk for women with endometriosis or fibroids.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
BACKGROUND: Recent studies have called into question the long-held belief that hysterectomy without oophorectomy protects against ovarian cancer. This population-based longitudinal record-linkage study aimed to explore this relationship, overall and by age at hysterectomy, time period, surgery type, and indication for hysterectomy. METHODS: We followed the female adult Western Australian population (837 942 women) across a 27-year period using linked electoral, hospital, births, deaths, and cancer records. Surgery dates were determined from hospital records, and ovarian cancer diagnoses (n = 1640) were ascertained from cancer registry records. We used Cox regression to estimate hazard ratios (HRs) and 95% confidence intervals (CIs) for the association between hysterectomy and ovarian cancer incidence. RESULTS: Hysterectomy without oophorectomy (n = 78 594) was not associated with risk of invasive ovarian cancer overall (HR = 0.98, 95% CI = 0.85 to 1.11) or with the most common serous subtype (HR = 1.05, 95% CI = 0.89 to 1.23). Estimates did not vary statistically significantly by age at procedure, time period, or surgical approach. However, among women with endometriosis (5.8%) or with fibroids (5.7%), hysterectomy was associated with substantially decreased ovarian cancer risk overall (HR = 0.17, 95% CI = 0.12 to 0.24, and HR = 0.27, 95% CI = 0.20 to 0.36, respectively) and across all subtypes. CONCLUSIONS: Our results suggest that for most women, having a hysterectomy with ovarian conservation is not likely to substantially alter their risk of developing ovarian cancer. However, our results, if confirmed, suggest that ovarian cancer risk reduction could be considered as a possible benefit of hysterectomy when making decisions about surgical management of endometriosis or fibroids.
My notes (saved in your browser only)
Condition tags
MeSH descriptors
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (34)
- Hormonal and surgical treatments for endometriosis and risk of epithelial ovarian cancer via openalex
- Oral contraceptive use, reproductive history, and risk of epithelial ovarian cancer in women with and without endometriosis via openalex
- Ovarian Cancer Risk Factors by Histologic Subtype: An Analysis From the Ovarian Cancer Cohort Consortium via openalex
- Relationship of Benign Gynecologic Diseases to Subsequent Risk of Ovarian and Uterine Tumors via openalex
- The Risk of Epithelial Ovarian Cancer of Women With Endometriosis May be Varied Greatly if Diagnostic Criteria Are Different via openalex
- doi:10.1007/s10552-011-9782-z via openalex
- doi:10.1016/j.fertnstert.2014.03.041 via openalex
- doi:10.1097/gme.0b013e31818ffe28 via openalex
- doi:10.1002/sim.5347 via openalex
- doi:10.1071/ah080766 via openalex
- doi:10.1007/s004320000153 via openalex
- doi:10.1136/jech.2008.083774 via openalex
- doi:10.1097/grf.0b013e31824b4611 via openalex
- doi:10.1002/ijc.23287 via openalex
- doi:10.1016/s0090-8258(02)00095-1 via openalex
- doi:10.1097/00001648-199911000-00018 via openalex
- doi:10.1136/bmj.38483.669178.8f via openalex
- doi:10.1093/aje/kwf048 via openalex
- W2567529666 via openalex
- W6628117348 via openalex
- doi:10.1093/aje/kwx055 via openalex
- doi:10.1016/j.ejca.2008.07.009 via openalex
- doi:10.1093/ije/26.3.476 via openalex
- doi:10.1136/bmjopen-2016-011822 via openalex
- doi:10.1016/s1047-2797(01)00213-7 via openalex
- doi:10.1016/j.annepidem.2010.10.002 via openalex
- doi:10.1016/j.ygyno.2007.06.006 via openalex
- doi:10.1016/j.ejca.2013.07.005 via openalex
- doi:10.1093/oxfordjournals.aje.a117296 via openalex
- doi:10.1007/978-1-60327-492-0_20 via openalex
- doi:10.1001/jama.288.3.321 via openalex
- doi:10.1002/ijc.28249 via openalex
- W1264843078 via openalex
- doi:10.1200/jco.2012.45.5758 via openalex
Cited by (10)
- Co-occurrence of endometriosis and uterine fibroids: a systematic review and meta-analysis 2025
- Research progress on correlative prediction factors and prediction models of endometriosis associated ovarian carcinoma 2024
- Hysterectomy—a possible risk factor for operative intervention in female patients for degenerative lumbar spine conditions: a case control and cohort study 2024
- Hysterectomy and risk of epithelial ovarian cancer by histologic type, endometriosis, and menopausal hormone therapy 2023
- Racial Differences in the Association of Endometriosis and Uterine Leiomyomas With the Risk of Ovarian Cancer 2023
- Effects of risk factors for ovarian cancer in women with and without endometriosis 2022
- Hysterectomy and risk of epithelial ovarian cancer by histologic type, endometriosis, and menopausal hormone therapy 2022
- Endometriosis and endometriosis associated ovarian cancer 2021
- Endometriosis and menopausal hormone therapy impact the hysterectomy-ovarian cancer association 2021
- Endometriosis-Associated Ovarian Cancer: The Origin and Targeted Therapy 2020
Source provenance
- europepmc
- last seen: 2026-09-02T07:05:44.937405+00:00
- openalex
- last seen: 2026-05-10T10:23:47.420568+00:00
- pubmed
- last seen: 2026-05-13T22:23:01.605684+00:00
License: CC0
· commercial use OK